Loading…
Based on limited metadata, the FDA issued a Warning Letter to Prolifix Nutrition, LLC on November 20, 2019, regarding dietary supplement products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA oversight of the dietary supplement industry, though the specific issuing office is not identified in the provided metadata. To understand the particular compliance issues cited, review of the complete Warning Letter would be necessary.